features: General

A report published in JAMA Oncology suggests that cancer patients with baseline immunosuppression and COVID-19 experience worse outcomes and an…

In a nationwide effort to prioritize and accelerate translational research, a brand-new oncology research collaboration has been established by The…

The early detection of cancer improves outcomes for patients – in terms of both reducing treatment burden and improving the…

In light of the ongoing COVID-19 pandemic, the National Institute for Health and Care Excellence (NICE) have put together a…

Cellular therapies are an exciting area in cancer research and clinical trials. The most widely known, CAR T-cell therapy, has…

The Health Policy Partnership and an expert-led steering committee met at the European Parliament in Brussels on the 22nd of…

Q&A with Nishali Patel, Clinical Lead of Digital Medicines and Pharmacy at NHS Digital, Cancer Services Pharmacist at University College…

Completed by a total of 3,981 cancer patients across 10 countries, All.Can is the biggest survey of its kind aiming…

Bevacizumab-bvzr (Zirabev; Pfizer), a biosimilar to bevacizumab (Avastin; Genentech) has been given the go-ahead by the FDA for five indications….

Are you ready for ESMO 2017? The Video Journal of Oncology is excited to be attending the ESMO 2017 Congress…

It has been known for almost a century that thoracic radiotherapy can cause damage to the heart.[2] However, the first…

At the European Cancer Congress 2017 in Amsterdam, the European Cancer Patient Coalition launched a new white paper on the…